Condition
Polyneuropathies clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Polyneuropathies clinical trials that are recruiting, at sites in 27 countries (most in Brazil (2), United States (2), Norway (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 27Countries
Newest Polyneuropathies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ultrasound-guided ulnar nerve PCR test to diagnose and monitor leprosy | — | Brasília, Federal District | Recruiting | Apr 7, 2026 |
| Ultrasound check for intramuscular bleeding after needle EMG in people taking DOACs | — | Brno, Czech Republic and 1 other locations | Recruiting | Sep 10, 2025 |
| Evaluating 100 Hz Tetanic Stimulation for Diagnosing Neuromuscular Block | — | Debrecen, Hajdú-Bihar and 1 other locations | Recruiting | Jan 1, 2025 |
| Preventing transthyretin amyloidosis in young carriers of a genetic variant | Phase 3 | La Jolla, California and 103 other locations | Recruiting | Aug 21, 2024 |
| Advancing genomic medicine using electronic health records | — | Philadelphia, Pennsylvania | Recruiting | Apr 22, 2024 |
| Exploring genetic factors in neuropathic pain | — | Bergen and 4 other locations | Recruiting | Mar 5, 2019 |
All recruiting trials (6)
-
Ultrasound-guided ulnar nerve PCR test to diagnose and monitor leprosy
This test uses an ultrasound-guided needle sample from the ulnar nerve combined with PCR to see if it can detect Mycobacterium leprae and help diagnose or monitor people with suspected or confirmed leprosy.
-
Ultrasound check for intramuscular bleeding after needle EMG in people taking DOACs
Ultrasound will be used about 30 minutes after a needle EMG to see if people taking direct oral anticoagulants (DOACs) develop intramuscular hematomas.
-
Evaluating 100 Hz Tetanic Stimulation for Diagnosing Neuromuscular Block
This study is testing a new way to check if patients have leftover muscle weakness after surgery by using a special electrical stimulation method to see how their muscles respond.
-
Preventing transthyretin amyloidosis in young carriers of a genetic variant
This study is testing if a medication called acoramidis can help prevent transthyretin amyloidosis in young adults who carry a specific genetic variant that puts them at risk for the disease.
-
Advancing genomic medicine using electronic health records
This study is trying to see if using electronic health records and helpful reminders can get more patients tested for genetic conditions in a way that doctors can easily use.
-
Exploring genetic factors in neuropathic pain
This study is trying to find out if certain genes are linked to neuropathic pain to help understand why some people experience this condition.
Related topics
Quick answers
How many Polyneuropathies clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 27 countries. The most sites are in Brazil (2 trials), United States (2 trials), Norway (1 trial), Argentina (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.